StockTipsArenaBeta

BUY Ajanta Pharma Limited — Kiran Jani, Jainam Broking

BUYAjanta Pharma Limited

byKiran Jani, Jainam BrokingHorizon: 1–3 months26 May 2026via Business Today

Entry₹3,100.4Inferred
Target₹3,600
Total upside +16.11% (call closed)
Stop loss₹2,100-32.27% risk
Exit₹3,60013 Aug 2026, 12:08 pm
Target hit+16.11%0.00%upside left
Follow Kiran Jani for new calls(17% target hit, 12 closed calls)Get alertsWatch AJANTPHARM for new buy/sell callsGet alertsSee 1 active Short-term call on AJANTPHARMSee 16 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 13 Aug 2026
6 supporting2 neutral4 opposing
Supports the BUY call (6)

4 advisors have active long-term BUY calls on this stock, with 3 issued in the last 14 days

Advisor consensus · adjacent horizon·10 Aug · 3d ago

Q1 Results Today Highlights: Swiggy narrows loss, Bajaj Finance, M&M, Gillette, Vedanta, Vedanta Aluminium, Ajanta Pharma, IRFC, ICRA, Niva Bupa profit rise, Hyundai PAT down; Torrent Pharma PAT up 3.3%; Tata Steel profit jumps 19%, NSDL's PAT up 9%

NewsHbl·30 Jul · 2w ago

(opens in new tab)

Dividend Alert: Ajanta Pharma Announces Interim Dividend — Check Record Date, Payout Date

NewsNdtv-Profit·30 Jul · 2w ago

(opens in new tab)

Ajanta Pharma Q1 profit jumps 31% on strong US sales; declares ₹32 dividend

NewsCnbc-Tv18·30 Jul · 2w ago

(opens in new tab)

Cipla, Ajanta Pharma to Alkem Laboratories: Pharma stocks rise amid weak trends on Dalal Street

NewsLivemint·20 Jul · 3w ago

(opens in new tab)
Neutral / worth noting (2)

Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·30 Jul · 2w ago

(opens in new tab)
Weighs against the BUY call (4)

Ajanta Pharma షేర్ ధర పడిపోయింది.. కారణం ఇదే!

NewsGoogle News·5 Aug · 1w ago

(opens in new tab)

Ajanta Pharma Share: डिविडेंड रिकॉर्ड डेट पर **3%** गिरा शेयर, जानिए क्या है वजह

NewsGoogle News·5 Aug · 1w ago

(opens in new tab)

Ajanta Pharma Share Price: डिव्हिडंडमुळे शेअर पडला 3%, पण ही आहे खरी बातमी!

NewsGoogle News·5 Aug · 1w ago

(opens in new tab)

Trump's tariff policy: Abbott India, Ajanta Pharma to Alembic — pharma stocks crash up to 4%

NewsLivemint·24 Jul · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.